On October 27, 2009, the Company issued a press release announcing its financial and operating results for the three months and nine months ended September 30, 2009, revised 2009 financial guidance and several strategic initiatives. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein in its entirety by reference.

The information furnished in this Item, including the exhibit, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.

(d) Exhibits

Exhibit
  No.                                     Description

99.1         Press release dated October 27, 2009 of Pharmaceutical Product
             Development, Inc. announcing its financial and operating results for
             the three months and nine months ended September 30, 2009, revised
             2009 financial guidance and several strategic initiatives. (Furnished
             pursuant to Item 2.02, not filed; see Item 2.02 above.)